CURE’s anal cancer page is an extensive resource of cancer information featuring the latest anal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on anal cancer.
September 21st 2022
Cancer made me more empathetic, as well as an advocate for the HPV vaccine.
September 6th 2022
After I was diagnosed with anal cancer, doctors wanted me to get an colostomy bag, but I refused. Later on, I had to voice my concern about a drug that could improve my chances for survival.
January 22nd 2021
The priority review will focus on retifanlimab for the treatment of certain adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal who did not tolerate platinum-based chemotherapy. Currently, according to Incyte, there are no approved treatments for this patient population.
August 24th 2020
To halt the rise of anal cancer, everyone eligible needs to be vaccinated against HPV, which causes most cases of the disease.
February 25th 2020
Sexual and gender minorities are not receiving the same standard of clinical care as other patients with cancer.
February 13th 2020
HPV and Anal cancer are associated with one another, here's what you need to know.
June 7th 2019
From today’s top entertainers to racial disparities in access to pain treatment, here’s what is making headlines in the cancer space this week.
October 6th 2018
The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.
July 25th 2018
A recent study found that socioeconomic status can play a role in survival for patients with anal cancer.
February 27th 2018
Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.
August 3rd 2017
More personalized approaches are being developed to treat patients with metastatic disease.
May 18th 2017
Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.
April 11th 2017
The PD-1 inhibitor, Opdivo, may be a promising option for patients with advanced anal cancer, according to a recent study.
January 27th 2017
From stigma to convenience, there are many reasons why people do not get the HPV vaccine, although it can prevent some types of cancer. Lois Ramondetta, M.D., discusses updated recommendations and hopes for getting more young people vaccinated.
July 12th 2016
Opdivo may be a promising treatment option for patients with squamous cell carcinoma of the anal canal.
April 17th 2015
A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.
February 20th 2015
States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.
November 25th 2014
NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.
March 14th 2013
Cases of HPV-related cancers are on the rise, specifically those associated with head and neck and anal cancers.
March 13th 2013
In the right cancer, radiation and chemotherapy can make a powerful duo.